Tag: Immunotherapy
Peptide Immunotx Well Tolerated in New-Onset Type 1 Diabetes
No decline in C-peptide with peptide immunotherapy; no change in insulin use over 12 months
Cost-Effectiveness of Allergen Immunotherapy Evaluated
AIT may be cost-effective for allergic rhinitis and in high-risk groups for venom allergy
Immunotherapy Efficacy Up With Gal-1/SIT Co-Administration
Suppressed allergic responses in mouse intestine with Gal-1, allergen-specific immunotherapy
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein
Grass Pollen SLIT Slows Course of Allergic Rhinitis, Asthma
Tx associated with slower AR progression, less frequent asthma onset, slower asthma progression
Short-Term Benefits for Immunotherapy in Allergic Asthma
Reductions seen in short-term symptom scores and medication scores, with evidence of publication bias
Quality of Life May Drop for Some During Oral Immunotherapy
Patients with better QOL at baseline, might deteriorate after therapy
AAN: Early Research Promising for Immunotherapy in MS
Investigators employ the relationship between MS and Epstein-Barr virus
AACR: Atezolizumab Aids Some With Triple-Negative Breast CA
A minority of women with triple-negative tumors responded to atezolizumab, but they responded well
ASCO: Antibiotics May Have Negative Impact in Renal Cancer
Progression-free survival down with antibiotic use for patients receiving immune checkpoint inhibitors
